On 28 June 2016,  Mayne Pharma Group Limited  (ASX Code: MYX) (Company) announced a fully underwritten 1 for 1.725 accelerated non-renounceable pro-rata entitlement offer of new ordinary shares in the Company at an issue price of $1.28 per new share to raise approximately $601 million (Entitlement Offer).

The Entitlement Offer has the following two components.

• An institutional entitlement offer, where offers have been made to
  eligible institutional shareholders for them to apply for their pro-rata
  entitlement (Institutional Entitlement Offer).  
• A retail entitlement offer, where offers will be made to eligible retail shareholders for them to apply for their pro‑rata entitlement (Retail Entitlement Offer).

New ordinary shares issued under the Entitlement Offer will rank
equally in all respects with existing ordinary shares.

The anticipated timetable in relation to the Entitlement Offer is set out below.

Settlement issues

Despite the fact that securities are trading ‘ex entitlement’ on ASX Trade, CHESS will not recognise for settlement purposes the ‘ex entitlement’ or the ‘cum entitlement’ tag on CHESS messages and CHESS will not maintain cum balances during the deemed ‘CHESS ex-period’, i.e. the period commencing on the deemed CHESS ex-date up to and including the record date. However, a record date cum balance will be available the business day following the record date, which will be equal to the registered holding balance at CHESS end of day on the record date. As a result any transfer that occurs prior to record date will be effectively transferred on a ‘cum entitlement’ basis.

Therefore, Participants must ensure that any transfer, including the priming of Broker Entrepot Accounts, is conducted in accordance with the basis of quote. For example, a transfer in relation to a transaction conducted on an ‘ex entitlement’ basis should ordinarily only occur post record date.

CHESS will perform automatic diary adjustments to ‘cum entitlement’ settlement obligations outstanding as at the record date.

Trading issues

ASX will not price a ‘cum entitlement’ market with respect to trading in the Company’s securities. Persons who acquire the Company’s securities after the commencement of the trading halt on Tuesday, 28 July 2016 are not entitled to participate in the Entitlement Offer.

What do I need to do by when?

For further details, please refer to the Company’s announcements.

Need more information?

For further information, please contact the Company’s Entitlement Offer Information Line on 1300 850 505 within Australia or +61 3 9415 4000 outside Australia from 8.30am to 5:00 pm (Melbourne time) Monday to Friday.

Issued by

Cheng Tang

Contact information

Cheng Tang
+61 (03) 9617 8706
info@asx.com.au

Disclaimer